The Comité Économique des Produits de Santé (CEPS) is an interministerial body under the joint authority of the French ministers responsible for health, social security, and the economy. Its primary role is to set the prices of medicines and tariffs for medical devices reimbursed by mandatory health insurance.
Core Functions of CEPS
CEPS’s main responsibilities include:
- Price Setting: Establishing prices for medicines and tariffs for medical devices intended for individual use that are covered by mandatory health insurance.
- Policy Contribution: Proposing and contributing to the development of economic policies related to health products.
Leadership and Key Contacts
As of February 2025, CEPS is led by President Virginie Beaumeunier The organization comprises two sections:
- Medicines Section: Vice-President Jean-Patrick Sales oversees this section.
- Medical Devices Section: Vice-President Bernard Celli leads this section.
Contact Details for CEPS
Website: https://sante.gouv.fr/ceps
Postal Address:
Comité Économique des Produits de Santé
14 avenue Duquesne
75350 Paris 07 SP, France
Challenges in Working with CEPS
Engaging with CEPS involves:
- Understanding Pricing Frameworks: Familiarity with CEPS’s criteria and procedures for price setting is crucial for successful market access. This includes relevant laws and the framework agreement (accord cadre) between the CEPS and the industry association LEEM.
- Timely and Accurate Submissions: Ensuring that all necessary documentation is complete and submitted promptly to facilitate the evaluation process and avoid penalties.
- Stakeholder Collaboration: Working effectively with various healthcare stakeholders in France to align with CEPS’s guidelines and recommendations.
Successful collaboration with CEPS can lead to efficient market entry and favorable reimbursement outcomes in France.
Opportunities with Justin Stindt Consultants
Justin Stindt CEPS expertise ensures:
- Expert CEPS Submissions: Creating high-quality submissions for price negotiations and tariff settings.
- Market Access CEPS Strategies: Proven methods for optimizing pricing & reimbursement outcomes.
- Specialist CEPS Processes: In-depth knowledge of French health product pricing evaluations to accelerate approvals.
Justin Stindt Consultants specializes in helping clients prepare effective submissions and engage confidently with CEPS evaluations.
Case Studies
A Pharmaceutical Company’s Success with CEPS
Challenge:
A pharmaceutical company sought our assistance to obtain favorable pricing approval for a novel therapy in France.
Solution:
Justin Stindt Consultants guided them in preparing a comprehensive dossier that addressed CEPS’s evaluation criteria and supported the company throughout the entire negotiations process.
Outcome:
Our strategic approach led to an attractive negotiated price, and inclusion in the national reimbursement list.
Need support with CEPS market access? Justin Stindt Consultants has the expertise to help you succeed.
Other Key Institutions in Market Access
Global Institutions
- World Health Organization (WHO)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
United States
- Centers for Medicare & Medicaid Services (CMS)
- Academy of Managed Care Pharmacy (AMCP)
- Institute for Clinical and Economic Review (ICER)
France
Germany
- Gemeinsamer Bundesausschuss (G-BA)
- Institute for Quality and Efficiency in Health Care (IQWiG)
- GKV Spitzenverband
United-Kingdom
- National Institute for Health and Care Excellence (NICE)
- Scottish Medicines Consortium (SMC)
- All Wales Medicines Strategy Group (AWMSG)
- National Health Service (NHS)
Italy
Spain
- Spanish Agency of Medicines and Medical Devices (AEMPS)
- Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia (DGCF)
- Interministerial Commission on Medicine Prices (CIPM)